Skip to main content

Fact-Checking Claims From Night 2 of the Democratic Debate

Ten Democrats seeking the presidency sparred on a Miami stage Thursday in the second night of the opening round of 2020 campaign debates.

Here’s a look at some of their statements and how they compare with the facts.

BERNIE SANDERS: Under Medicare for All, “the vast majority of the people in this country will be paying significantly less for health care than they are now.”

THE FACTS: Probably true, but that’s only part of the equation for a family. The Vermont senator’s plan for a government-run health care system to replace private insurance calls for no premiums, and no copays and deductibles. But taxes would have to go up significantly as the government takes on trillions of dollars in health care costs now covered by employers and individuals. Independent studies estimate the government would be spending an additional $28 trillion to $36 trillion over 10 years, although Medicare for All supporters say that’s overstating it.

How those tax increases would be divvied up remains to be seen, as Sanders has not released a blueprint for how to finance his plan.

More must-read stories from Fortune:

--4 times 2020 candidates clashed during the Democratic debate

--5 things to watch for on night 2 of the Democratic presidential debate

--What the 2020 Democratic candidates didn't say during the first debate

--Elizabeth Warren holds her own as lesser-knowns break out in first debate

--Juli?n Castro breaks out in a debate defined by border policy and immigration

--Can socialism win in 2020? Democrats aren’t embracing it



from Fortune https://ift.tt/31UQovC
Labels:

Comments

Post a Comment

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $
Post a Comment
Read more

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be
Post a Comment
Read more